Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

76971 Press Releases
DateTitleCompany
21 Jan 13 Research and Markets: Novartis - IMS Company Profiles - Gain a Comprehensive Picture of the Company's Strategic Direction Research and Markets,
Published by
Business Wire
21 Jan 13 Open Monoclonal Technology and Recombinant Antibody Technology Announce OmniRat™ Scientific Publication Open Monoclonal Technology Inc.,
Published by
Business Wire
21 Jan 13 Mallinckrodt Announces Approval of New Gablofen® Prefilled Syringe Covidien,
Published by
Business Wire
21 Jan 13 Research and Markets: Healthcare, Regulatory and Reimbursement Landscape - South Africa Research and Markets,
Published by
Business Wire
21 Jan 13 Research and Markets: Secukinumab (Rheumatoid Arthritis) Forecast and Market Analysis Research and Markets,
Published by
Business Wire
21 Jan 13 Research and Markets: Fostamatinib (Rheumatoid Arthritis) Forecast and Market Analysis Research and Markets,
Published by
Business Wire
21 Jan 13 Research and Markets: Tabalumab (Rheumatoid Arthritis) Forecast and Market Analysis Research and Markets,
Published by
Business Wire
21 Jan 13 Research and Markets: Xeljanz (tofacitinib) (Rheumatoid Arthritis) Forecast and Market Analysis Research and Markets,
Published by
Business Wire
21 Jan 13 FDA Issues Complete Response Letter for RYTARY™ (Carbidopa and Levodopa) Extended-Release Capsules (IPX066) New Drug Application Impax Laboratories Inc.,
Published by
Business Wire
21 Jan 13 Research and Markets: PharmaPoint: Rheumatoid Arthritis - Italy Drug Forecast and Market Analysis Event-Driven Update Research and Markets,
Published by
Business Wire
21 Jan 13 Research and Markets: Sirukumab (Rheumatoid Arthritis) Forecast and Market Analysis Research and Markets,
Published by
Business Wire
21 Jan 13 Nordion to Release Fourth Quarter and Fiscal 2012 Financial Results Nordion Inc.,
Published by
Business Wire
21 Jan 13 Nordion Files Amended Statement of Claim in IPFA Proceedings Nordion Inc.,
Published by
Business Wire
21 Jan 13 Amunix Announces Licensing Agreement For Its Proprietary XTEN Technology Amunix Inc.,
Published by
Business Wire
21 Jan 13 Research and Markets: Cataract - Pipeline Review, H2 2012 Research and Markets,
Published by
Business Wire
21 Jan 13 Research and Markets: Pharmaceutical Directory of China 2013 Research and Markets,
Published by
Business Wire
21 Jan 13 Research and Markets: International Directory of Pharmaceutical Companies 2013 Research and Markets,
Published by
Business Wire
21 Jan 13 Research and Markets: Tinnitus - Pipeline Review, H2 2012 Research and Markets,
Published by
Business Wire
21 Jan 13 Research and Markets: Global Pharmaceutical & Biotechnology Outlook 2013: Japan Pharma Research and Markets,
Published by
Business Wire
21 Jan 13 Research and Markets: Cancer Peptides: From First-in-Class to Best-in-Class? - Base of 171 Peptide Drugs within the Portfolio of 114 Companies Research and Markets,
Published by
Business Wire
21 Jan 13 Almac Successfully Completes Knowledge Transfer Partnership with Queens University with Highest Accolade Almac Group,
Published by
De Facto Communications
21 Jan 13 Sectra Enters the Southeast Asian Market SECTRA,
Published by
Business Wire
21 Jan 13 DaVita Closes Deal to Provide Dialysis Services in Taiwan DaVita,
Published by
Business Wire
20 Jan 13 Arthritis a prevalent condition in 20% of the Middle Eastern population Informa Life Sciences Exhibitions
20 Jan 13 The Methodist Hospital Announces New CME Program on Heart and Oncology Care in Riyadh, Jeddah, and Dammam, Saudi Arabia The Methodist Hospital,
Published by
Business Wire
19 Jan 13 Lower Drug Pricing Key to Fix for Industry’s Image, Says AHF AIDS Healthcare Foundation,
Published by
Business Wire
19 Jan 13 BOTOX® (onabotulinumtoxinA) Receives U.S. Food and Drug Administration Approval for the Treatment of Overactive Bladder for Adults Who Have an Inadequate Response to or Are Intolerant of an Anticholinergic Medication Allergan Inc.,
Published by
Business Wire
19 Jan 13 Three Life Sciences Companies Find Their Space at the Science Center Port University City Science Center,
Published by
Business Wire
18 Jan 13 Reha Technology AG Receives Major Financing by International Healthcare Investor HBM BioCapital II REHA Technology AG,
Published by
PR Newswire
18 Jan 13 Mintz Levin’s William C. Hicks to Moderate Panel at 2013 BIO CEO and Investor Conference Mintz Levin Cohn Ferris Glovsky and Popeo P.C.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.